{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:14:38Z","timestamp":1788862478189,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"IFCAH"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jsbmb.2019.105540","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T11:42:32Z","timestamp":1573558952000},"page":"105540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency"],"prefix":"10.1016","volume":"197","author":[{"given":"Luisa","family":"Paizoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias K.","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2019.105540_bib0005","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jsbmb.2016.06.015","article-title":"Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia","volume":"165","author":"Parsa","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0015","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 5","key":"10.1016\/j.jsbmb.2019.105540_bib0020","first-page":"158","article-title":"Adult consequences of congenital adrenal hyperplasia","volume":"68","author":"Arlt","year":"2007","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0025","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0030","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jc.2006-1711","article-title":"Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"92","author":"Sartorato","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0035","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1210\/jc.2014-2957","article-title":"Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0040","first-page":"270","article-title":"Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia","volume":"63","author":"Saygili","year":"2005","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0045","first-page":"268","article-title":"Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"67","author":"Bachelot","year":"2007","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0050","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1210\/jc.2018-01862","article-title":"Cardiovascular and metabolic outcomes in congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"103","author":"Tamhane","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.05.004","article-title":"Congenital adrenal hyperplasia\u2014pharmacologic interventions from the prenatal phase to adulthood","volume":"132","author":"Claahsen-Van Der Grinten","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0060","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2019.105540_bib0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/jc.2012-3343","article-title":"Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort","volume":"98","author":"Krone","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1210\/jc.2006-1350","article-title":"Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"92","author":"Falhammar","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/EJE-10-0877","article-title":"Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"164","author":"Falhammar","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0080","first-page":"207","article-title":"Regional differences in the prevalence of the metabolic syndrome in primary care practices in Germany","volume":"105","author":"Moebus","year":"2008","journal-title":"Deutsches \u00c4rzteblatt Int."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0085","article-title":"A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia","volume":"1001","author":"Mallappa","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0090","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1530\/eje.0.1430667","article-title":"Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocortioid treatment since infancy","volume":"143","author":"Hagenfeldt","year":"2000","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0095","volume":"Vol 56","author":"Mensink","year":"2013"},{"key":"10.1016\/j.jsbmb.2019.105540_bib0100","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jc.2002-021074","article-title":"Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0105","first-page":"2238","article-title":"Bone mineral density and body composition in congenital adrenal hyperplasia","volume":"80","author":"Cameron","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000075588","article-title":"Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"61","author":"Christiansen","year":"2004","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0115","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/jc.2017-01559","article-title":"Effects of sex hormone treatment on the metabolic syndrome in transgender individuals: focus on metabolic cytokines","volume":"103","author":"Auer","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0120","first-page":"337","article-title":"Serum androgen levels and muscle mass in women with polycystic ovary syndrome","volume":"94","author":"Douchi","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0125","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jc.2006-1711","article-title":"Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"92","author":"Sartorato","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03346751","article-title":"Increased large artery intima media thickness in adolescents with either classical or non-classical congenital adrenal hyperplasia","volume":"36","author":"Wasniewska","year":"2013","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0135","first-page":"154","article-title":"Intima media thickness of common carotids and abdominal aorta in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in relation to their genotypes","volume":"38","author":"Janus","year":"2017","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000444169","article-title":"Carotid intima-media thickness is associated with increased androgens in adolescents and young adults with classical congenital adrenal hyperplasia","volume":"85","author":"Kim","year":"2016","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/HJH.0000000000001850","article-title":"Early central blood pressure elevation in adult patients with 21-hydroxylase deficiency","volume":"37","author":"Rosenbaum","year":"2019","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0150","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1515\/jpem-2017-0068","article-title":"Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency","volume":"30","author":"Mooij","year":"2017","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2265.2003.01757.x","article-title":"Blood pressure in children and adolescents with congenital adrenal hyperplasia (21\u2010hydroxylase deficiency): a preliminary report","volume":"58","author":"Roche","year":"2003","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000086363","article-title":"Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia","volume":"63","author":"Sayg\u0131l\u0131","year":"2005","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0165","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/EJE-15-0064","article-title":"Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers","volume":"173","author":"Debono","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0170","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jc.2016-3989","article-title":"11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency","volume":"8","author":"Turcu","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0175","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"5","author":"Turcu","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0180","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0185","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2337\/db14-0395","article-title":"Glucocorticoids transcriptionally regulate miR-27b expression promoting body fat accumulation via suppressing the browning of white adipose tissue","volume":"64","author":"Kong","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jsbmb.2019.105540_bib0190","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2016.06.011","article-title":"Glucocorticoids acutely increase brown adipose tissue activity in humans, revealing species-specific differences in UCP-1 regulation","volume":"24","author":"Ramage","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0195","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1210\/js.2019-00123","article-title":"Impact of long-term dexamethasone therapy on the metabolic profile of patients with 21-hydroxylase deficiency","volume":"3","author":"Seraphim","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0200","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1001\/archinte.1992.00400210081013","article-title":"Clinical relevance of nighttime blood pressure and of daytime blood pressure variability","volume":"152","author":"Palatini","year":"1992","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005344-199412001-00006","article-title":"Nocturnal hypertension and cardiovascular risk: consequences for diagnosis and treatment","volume":"24","author":"Grote","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0210","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/00004872-200208000-00011","article-title":"The majority of nondipping men do not have increased cardiovascular risk: a population-based study","volume":"20","author":"Bj\u00f6rklund","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0215","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12020-010-9382-9","article-title":"Metabolic disorders in newly diagnosed young adult female patients with simple virilizing 21-hydroxylase deficiency","volume":"38","author":"Zhang","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.jsbmb.2019.105540_bib0220","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0225","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1210\/jcem.86.10.7972","article-title":"Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?","volume":"86","author":"Charmandari","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105540_bib0230","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1210\/jcem.87.3.8297","article-title":"Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"87","author":"Gr\u00f6schl","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019304388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019304388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:05:39Z","timestamp":1760745939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076019304388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":46,"alternative-id":["S0960076019304388"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105540","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105540"}}